News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BerGenBio AS Presents Positive Phase Ia Data On BGB324 At American Association for Cancer Research


4/9/2014 11:09:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BERGEN, Norway, April 9, 2014 /PRNewswire via COMTEX/ -- BERGEN, Norway, April 9, 2014 /PRNewswire/ --

or the "Company"), an oncology biopharmaceutical company, announces that results from its successful Phase Ia clinical study for lead compound, BGB324, was presented at the American Association of Cancer Research annual conference, which took place on April 5-9, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES